<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220107053654N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-22</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of intravenous dexamethasone and acetaminophen on postoperative pain and agitation children undergoing general anesthesia for dental rehabilitation</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of intravenous dexamethasone and intravenous acetaminophen (apotel) on postoperative pain and agitation of 2-6-year-old children undergoing general anesthesia for dental rehabilitation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-03-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61538</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is simple and its unit is the individual. Randomizing the table of random numbers is our tool. Patients will be randomly assigned treatment types. In this way, each vial is randomly selected based on the envelope randomization process, and an operating room nurse who is not a member of the research team selects the drugs that will be used. Due to this, neither the patient nor the researcher is aware of the type of treatment chosen, ensuring blindness in the bilateral study, Blinding description: The present study is double-blind. For blinding the contents of the vials will be specified with the code A (intravenous dexamethasone) and B (Apotel), and will be placed inside sealed envelopes (envelope); An operating room nurse who is not a member of the research team randomly selects the drugs used. The nurse registers the variables at the end of the operation and participants are blind to the content of the syringes used.</study_design>
      <phase>2</phase>
      <hc_freetext>The amount of pain after dental treatment under general anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: 20 children aged 2-6 years referred to the pediatric ward of Tehran University of Medical Sciences who are candidates for dental treatment under general anesthesia.These patients receive intravenous dexamethasone 0.5 mg/kg immediately after induction after obtaining informed consent and preparing the patient for treatment under anesthesia.Except for fentanyl used at the beginning of anesthesia, no opioid analgesics NSAIDs, or antiemetics are used 24 hours before and during the operation, and none of the patients receive local anesthesia before dental interventions. At the end of the operation, after the patient returns to breathing, the reverse of the neuromuscular block is slowly injected and the patient is extruded while awake. Treatment is performed and within the first 30 minutes after recovery as well as the time of discharge, pain, nausea, and vomiting in the presence/absence of it, mild/moderate/severe sore throat and agitation are evaluated and recorded by a trained nurse. During telephone calls with parents within 24 hours after discharge, the presence of sore throat nausea, and vomiting are recorded again. Intervention 2: Intervention group 2: 20 children aged 2-6 years referred to the pediatric ward of Tehran University of Medical Sciences who are candidates for dental treatment under general anesthesia.After obtaining informed consent and preparing the patient for treatment under anesthesia, these patients receive 15 mg/kg of Apotel in ten minutes in the last 15 minutes.During the treatment, except for fentanyl used at the beginning of anesthesia, no opioid analgesics NSAIDs, or anti-nausea is used in the 24 hours before and during the operation, and none of the patients receive local anesthesia before dental interventions. At the end of the operation, after the patient returns to breathing, the reverse of the neuromuscular block is slowly injected and the patient is extruded while awake. Within the first 30 minutes after recovery, as well as the time of discharge, pain, nausea, and vomiting in the presence/absence of it, mild/moderate/severe sore throat and agitation are assessed and recorded by a trained nurse. During telephone calls with parents within 24 hours after discharge, the presence of sore throat nausea, and vomiting are recorded again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeide Mokhtari Khoei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Karegar  St,Tehran-Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۹۹۵۵۹۹۱</zip>
        <telephone>+98 21 4279 4500</telephone>
        <email>sa.mokhtari@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Saeide Mokhtari Khoei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Karegar  St,Tehran-Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۳۹۹۵۵۹۹۱</zip>
        <telephone>+98 21 4279 4500</telephone>
        <email>sa.mokhtari@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children 2 to 6 years old are candidates for general anesthesia for dental rehabilitation
Children with ASA I, II status
Consent of the child and the child's parents to participate in the study</inclusion_criteria>
      <agemin>2 years</agemin>
      <agemax>6 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients need a tooth extraction
Patients with a history of chronic systemic diseases
Patients with a history of allergies to any of the drugs used in the study
Patients with a history of respiratory problems, allergies, motor, and mental illness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z48.814</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for surgical aftercare following surgery on the teeth or oral cavity</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: 20 children aged 2-6 years referred to the pediatric ward of Tehran University of Medical Sciences who are candidates for dental treatment under general anesthesia.These patients receive intravenous dexamethasone 0.5 mg/kg immediately after induction after obtaining informed consent and preparing the patient for treatment under anesthesia.Except for fentanyl used at the beginning of anesthesia, no opioid analgesics NSAIDs, or antiemetics are used 24 hours before and during the operation, and none of the patients receive local anesthesia before dental interventions. At the end of the operation, after the patient returns to breathing, the reverse of the neuromuscular block is slowly injected and the patient is extruded while awake. Treatment is performed and within the first 30 minutes after recovery as well as the time of discharge, pain, nausea, and vomiting in the presence/absence of it, mild/moderate/severe sore throat and agitation are evaluated and recorded by a trained nurse. During telephone calls with parents within 24 hours after discharge, the presence of sore throat nausea, and vomiting are recorded again.</i_keyword>
      <i_keyword>Intervention group 2: 20 children aged 2-6 years referred to the pediatric ward of Tehran University of Medical Sciences who are candidates for dental treatment under general anesthesia.After obtaining informed consent and preparing the patient for treatment under anesthesia, these patients receive 15 mg/kg of Apotel in ten minutes in the last 15 minutes.During the treatment, except for fentanyl used at the beginning of anesthesia, no opioid analgesics NSAIDs, or anti-nausea is used in the 24 hours before and during the operation, and none of the patients receive local anesthesia before dental interventions. At the end of the operation, after the patient returns to breathing, the reverse of the neuromuscular block is slowly injected and the patient is extruded while awake. Within the first 30 minutes after recovery, as well as the time of discharge, pain, nausea, and vomiting in the presence/absence of it, mild/moderate/severe sore throat and agitation are assessed and recorded by a trained nurse. During telephone calls with parents within 24 hours after discharge, the presence of sore throat nausea, and vomiting are recorded again.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain measurement. Timepoint: During the first 30 minutes after recovery, discharge time, 24 hours after discharge. Method of measurement: Children’s hospital of eastern Ontario pain score: CHEOPS.</prim_outcome>
      <prim_outcome>Nausea and vomiting. Timepoint: During the first 30 minutes after recovery, discharge time, 24 hours after discharge. Method of measurement: Checklist: its presence / absence.</prim_outcome>
      <prim_outcome>Sore throat. Timepoint: During the first 30 minutes after recovery, discharge time, 24 hours after discharge. Method of measurement: Checklist: Mild / Medium / Severe.</prim_outcome>
      <prim_outcome>Agitation. Timepoint: During the first 30 minutes after recovery, discharge time, 24 hours after discharge. Method of measurement: PAED score (pediatric agitation emergence delirium score).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-29</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central office of Tehran University of Medical Sciences, Ghods St, Keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
